Defining the Human Insulin Resistance Molecular Network; SIGNATURE

NCT ID: NCT07255807

Last Updated: 2025-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-01

Study Completion Date

2038-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this intervention study is to learn more about what causes insulin resistance in otherwise healthy adults, and how short-term changes in physical activity or diet may influence it. The study includes healthy male and female participants aged 25 to 55 years, who meet specific health criteria.

The main questions it aims to answer are:

Does the cause of insulin resistance vary between individuals due to their genes and lifestyle?

Can the investigators identify different types (sub-phenotypes) of insulin resistance at the molecular level?

Researchers will compare groups who either reduce their physical activity for 14 days or consume a high-fat diet for 3 days, to see how these changes affect insulin sensitivity and related biological markers.

Participants will:

* Complete a health screening and be assessed for eligibility
* Undergo baseline testing to measure insulin sensitivity, physical activity, diet, and metabolic health
* Be randomly assigned to one of two short-term interventions (14 days of reduced physical activity, or 3 days of a high-fat, high-calorie diet)
* Repeat selected tests after the intervention to assess changes

This study will help researchers better understand how lifestyle and biology interact in the development of insulin resistance, even in people who are otherwise healthy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This intervention study aims to uncover the molecular mechanisms that underlie insulin resistance in otherwise healthy adults and to explore how short-term lifestyle changes may influence these mechanisms. Insulin resistance is a key feature in the development of type 2 diabetes and other metabolic diseases, but it does not arise uniformly across individuals. The overarching hypothesis is that insulin resistance has multiple underlying causes that differ between individuals, depending on genetic variation and modifiable lifestyle factors such as physical activity and diet.

A total of 80 healthy participants-40 males and 40 females aged between 25 and 55 years-will be recruited. All participants must have a body mass index (BMI) between 18 and 30 and meet strict inclusion and exclusion criteria to minimize confounding variables. Participants will be free of chronic disease, non-smokers, have limited alcohol intake, and not engage in high levels of physical activity. This controlled approach ensures a more accurate assessment of the variables under investigation.

At baseline, all participants will undergo comprehensive phenotyping, including assessments of habitual physical activity, dietary intake, glucose tolerance, and whole-body insulin sensitivity. This will allow the researchers to categorize sub-phenotypes of insulin resistance at both the physiological and molecular level.

Following baseline testing, 40 of the 80 participants will undergo one of two short-term interventions designed to stress metabolic pathways associated with insulin sensitivity:

* Reduced physical activity: Participants will significantly decrease their daily physical activity for 14 days.
* High-fat diet: Participants will consume a hypercaloric high-fat diet for 3 consecutive days.

The aim of these interventions is to test how short-term negative lifestyle changes impact insulin action and related molecular markers, and whether these responses vary between individuals with different phenotypic and genetic profiles.

After the intervention period, selected metabolic tests will be repeated to assess changes in insulin sensitivity and molecular signaling. The primary outcome measure is whole-body insulin action, assessed using gold-standard physiological methods. Exploratory outcomes include identifying cellular and molecular mechanisms contributing to insulin resistance, and understanding the interaction between gene expression and lifestyle responses.

By combining deep phenotyping with short-term interventions, this study will generate new insights into the biological diversity of insulin resistance. Ultimately, this may contribute to the development of more individualized strategies for the prevention and treatment of metabolic diseases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Health Insulin Sensitivity/Resistance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study uses a parallel design involving 80 healthy participants who all undergo comprehensive baseline assessments, including physiological and metabolic phenotyping, habitual physical activity, and dietary intake evaluations. Following baseline characterization, 40 participants are assigned to one of two independent intervention arms: 14 days of reduced physical activity or 3 days of a hypercaloric high-fat diet. Each intervention group is studied in parallel, with outcomes compared to assess the specific effects on insulin sensitivity and molecular mechanisms. The parallel design was chosen due to the invasive and time-intensive nature of the interventions and testing procedures, making a crossover design impractical and burdensome for participants.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Baseline Characterization

All participants (N=80) undergo extensive baseline characterization over three study visits. This includes assessments of insulin sensitivity, glucose tolerance, metabolic and physiological phenotyping, habitual physical activity, and dietary intake. No intervention is applied during this phase; the purpose is to establish baseline measures and characterize individual variation in insulin resistance and metabolic profiles.

Participants complete detailed clinical, physiological, and behavioral assessments without any experimental manipulation. This includes:

* Measurement of insulin action and glucose tolerance
* Dietary and physical activity profiling
* Collection of biospecimens for molecular analyses

Group Type NO_INTERVENTION

No interventions assigned to this group

Lifestyle Interventions

A subset of 40 participants are randomized into one of two experimental interventions following baseline assessment:

* 14 days of reduced physical activity (\<1,500 steps/day), or
* 3 days of a hypercaloric high-fat diet

The aim is to evaluate how short-term lifestyle stressors affect insulin sensitivity and related molecular markers. Assessments from visits 4 and 5 are compared to baseline to determine within-subject changes.

Intervention Names:

1. Reduced Physical Activity

\- Participants limit daily steps to \<1,500 for 14 days
2. High-Fat Diet

* Participants consume a hypercaloric, high-fat diet for 3 days

Description of Intervention:

Participants undergo one of the two lifestyle interventions with strict monitoring and support. Selected baseline tests are repeated post-intervention to evaluate metabolic and molecular responses.

Group Type EXPERIMENTAL

Physical Inactivity

Intervention Type BEHAVIORAL

Participants assigned to the physical inactivity intervention will reduce their daily physical activity to fewer than 1,500 steps per day for 14 consecutive days. This strict limitation significantly decreases overall movement and muscle activity, mimicking a sedentary lifestyle. The aim is to assess the short-term effects of reduced physical activity on insulin sensitivity and related metabolic processes. Compliance will be monitored using activity trackers and daily logs. Baseline metabolic and physiological assessments will be repeated after the intervention to evaluate changes.

Hypercaloric High-Fat Diet

Intervention Type BEHAVIORAL

Participants assigned to the high-fat diet intervention will consume a hypercaloric diet rich in fat for 3 consecutive days. The diet is designed to significantly increase caloric intake and fat consumption beyond habitual levels to induce short-term metabolic stress. This intervention aims to assess how a brief period of high-fat overfeeding affects insulin sensitivity and related molecular pathways. Participants' dietary intake will be carefully controlled and monitored to ensure adherence. Baseline metabolic and physiological assessments will be repeated after the intervention to evaluate changes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physical Inactivity

Participants assigned to the physical inactivity intervention will reduce their daily physical activity to fewer than 1,500 steps per day for 14 consecutive days. This strict limitation significantly decreases overall movement and muscle activity, mimicking a sedentary lifestyle. The aim is to assess the short-term effects of reduced physical activity on insulin sensitivity and related metabolic processes. Compliance will be monitored using activity trackers and daily logs. Baseline metabolic and physiological assessments will be repeated after the intervention to evaluate changes.

Intervention Type BEHAVIORAL

Hypercaloric High-Fat Diet

Participants assigned to the high-fat diet intervention will consume a hypercaloric diet rich in fat for 3 consecutive days. The diet is designed to significantly increase caloric intake and fat consumption beyond habitual levels to induce short-term metabolic stress. This intervention aims to assess how a brief period of high-fat overfeeding affects insulin sensitivity and related molecular pathways. Participants' dietary intake will be carefully controlled and monitored to ensure adherence. Baseline metabolic and physiological assessments will be repeated after the intervention to evaluate changes.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Reduced Activity Overeating

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 25-55 years
* Body Mass Index (BMI): 18-30 kg/m²
* Healthy (no diagnosed chronic diseases)
* Able and willing to comply with study procedures

Exclusion Criteria

* Smoking or nicotine use, current or within the past 5 years
* Alcohol intake exceeding 10 units per week
* Hemoglobin A1c (HbA1c) \> 48 mmol/mol (indicative of diabetes or prediabetes)
* Chronic diseases (e.g., cardiovascular disease, diabetes, etc.)
* Chronic medication use, including hormonal treatments
* High physical activity levels (more than 3 hours per week of moderate to vigorous exercise)
* Pregnancy or within 3 months postpartum
* Breastfeeding or within 3 months of cessation
* Abnormal routine blood markers (as defined in lab screening)
* Blood donation within the past 2 months
Minimum Eligible Age

25 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sydney

OTHER

Sponsor Role collaborator

Queen Mary University of London

OTHER

Sponsor Role collaborator

Novo Nordisk A/S

INDUSTRY

Sponsor Role collaborator

University of Copenhagen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jorgen FP Wojtaszewski

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jørgen F.P. Wojtaszewski, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of Copenhagen

Ylva Hellsten, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of Copenhagen

Henriette Pilegaard, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of Copenhagen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

August Krogh Building

Copenhagen, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jørgen F.P. Wojtaszewski, Ph.D.

Role: CONTACT

+45 28751625

Kate A Wickham, Ph.D.

Role: CONTACT

+45 30638013

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kate A Wickham, Ph.D.

Role: primary

+45 30638013

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NNF24OC0085866

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

SIGNATURE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Insulin Resistance Study
NCT00614757 SUSPENDED NA